Cited by 69Amyotrophic Lateral Sclerosis ResearchAlzheimer's disease research and treatmentsHereditary Neurological Disorders

Axonopathy and cytoskeletal disruption in degenerative diseases of the central nervous system

Open access
Vickers, James C., King, Anna E., Woodhouse, Adele, Kirkcaldie, Matthew T., Staal, Jerome A., McCormack, Graeme H., Blizzard, Catherine A., Musgrove, Ruth E.J. +5 more·2009·Brain Research Bulletin

Abstract

There has been growing interest in the axon as the initial focus of pathological change in a number of neurodegenerative diseases of the central nervous system. This review concentrates on three major neurodegenerative conditions--amyotrophic lateral sclerosis, multiple sclerosis and Alzheimer's disease--with emphasis on key cellular changes that may underlie early axonal dysfunction and pathology and, potentially, the degeneration of neurons. In particular, this review will address recent data that indicate that the main pathological stimuli for these conditions, though often not definitively determined, result in an initial perturbation of the axon and its cytoskeleton, which then results in slow neuronal degeneration and loss of connectivity. The identification of a degenerative process initiated in the axon may provide new therapeutic targets for early intervention to inhibit the grim outcomes related to the progression of these diseases.

Integrity signals

Registry

Crossref · 10.1016/j.brainresbull.2009.08.004

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The buildup of neurotoxic agents causes neuronal damage and death, which can lead to neurological dysfunction including cognitive decline, motor abnormalities, mental disorders, and loss of inhibition.

    “The buildup of neurotoxic agents is believed to cause neuronal damage and death, which can ultimately lead to various forms of neurological dysfunction that include cognitive decline, motor abnormalities, mental disorders, and loss of inhibition (Chung et al., 2018; Taylor et al., 2002; Vickers et al., 2009).”

    From SYK coordinates neuroprotective microglial responses in neurodegenerative disease (2022) · cites this paper as Vickers et al., 2009

The citation lists haven’t been fetched yet

References 108 · Cited by 69

Authors
Vickers, J. C., King, A. E., Woodhouse, A., Kirkcaldie, M. T., Staal, J. A., McCormack, G. H., Blizzard, C. A., Musgrove, R. E. J., Mitew, S., Liu, Y., Chuckowree, J. A., Bibari, O., & Dickson, T. C.
Affiliations
University of Tasmania (AU)
Corresponding author
Vickers, James C.
Venue
Brain Research Bulletin
Publisher
Elsevier BV
Published
2009-10
Volume
80
Issue
4-5
Pages
217-223
ISSN
0361-9230 (ISSN-L)
OpenAlex
W2006223466
Cited by
69
References
108
Citations by year
2025: 2 · 2024: 3 · 2023: 2 · 2022: 3 · 2021: 3 · 2020: 3 · 2019: 7 · 2018: 4 · 2017: 7 · 2016: 7 · 2015: 3 · 2014: 3 · 2013: 7 · 2012: 4
FWCI
0.56
Type
journal article
Language
en
Open access
Locations
  • Brain Research Bulletin (publishedVersion)
  • PubMed (publishedVersion)
  • eCite Digital Repository (University of Tasmania) (submittedVersion)
  • Figshare (submittedVersion, cc-by)
Topics
  • Health Sciences › Medicine › Neurology › Amyotrophic Lateral Sclerosis Research
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
Keywords
axonopathy, axonal cytoskeleton, neurodegeneration, amyotrophic lateral sclerosis, multiple sclerosis, Alzheimer's disease, axonal dysfunction, central nervous system degenerative diseases, therapeutic target
MeSH terms
Alzheimer Disease, Amyotrophic Lateral Sclerosis, Axons, Cytoskeleton, Humans, Multiple Sclerosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review